Overview
My research interests focus on issues affecting the translation of genomics to clinical practice. Specifically, I have a strong interest in education, with each of my research projects involving some component of professional, public or patient education, including development of educational materials about genomic research in general, pharmacogenetic testing, and communicating genetic test results, in addition to undergraduate teaching in genetics/genomics, ethics, and policy.
Areas of expertise: Bioethics and Health Behavior
Areas of expertise: Bioethics and Health Behavior
Current Appointments & Affiliations
Professor in Medicine
·
2023 - Present
Medicine, General Internal Medicine,
Medicine
Associate Research Professor in the Sanford School of Public Policy
·
2014 - Present
Sanford School of Public Policy
Associate Research Professor of Biology
·
2018 - Present
Biology,
Trinity College of Arts & Sciences
Affiliate of the Duke Initiative for Science & Society
·
2014 - Present
Duke Science & Society,
University Initiatives & Academic Support Units
Executive Team Member of Duke Center for Applied Genomics and Precision Medicine
·
2014 - Present
The Precision Medicine Program,
Medicine
Recent Publications
Advancing the science of genomic learning healthcare systems.
Journal Article Learn Health Syst · October 2025 INTRODUCTION: Identifying key characteristics of exemplar genomic learning healthcare systems (gLHS) and knowledge gaps that can be explored by collaboration among them is likely to accelerate the sharing of best practices and generation of evidence that i ... Full text Link to item CiteCharacterization of Research Support of Genome Editing Technologies and Transition to Clinical Trials.
Journal Article CRISPR J · October 2024 Genome editing technologies have become widely used research tools. To assess the rate of growth with respect to federal funding of gene editing projects, we analyzed publicly available data retrieved from the NIH RePORTER and Clinicaltrials.gov databases. ... Full text Link to item CitePharmacogenetic testing in primary care could bolster depression treatment: A value proposition.
Journal Article Clin Transl Sci · June 2024 Pharmacogenetic testing could reduce the time to identify a safe and effective medication for depression; however, it is underutilized in practice. Major depression constitutes the most common mental disorder in the US, and while antidepressant therapy can ... Full text Link to item CiteRecent Grants
Deploying a genomic-medicine risk assessment model for diverse primary care populations and settings
Clinical TrialPrincipal Investigator · Awarded by National Human Genome Research Institute · 2021 - 2026NHGRI Research Training and Career Development Annual Meeting
ConferencePrincipal Investigator · Awarded by National Institutes of Health · 2021 - 2026The Duke Sarnoff - Supporting Undergraduate Research Experiences (SURE) - Inioluwa Olabode
Inst. Training Prgm or CMEPrincipal Investigator · Awarded by American Heart Association · 2025 - 2025View All Grants
Education, Training & Certifications
University of Maryland, Baltimore ·
1999
Ph.D.